Top Markets
Coin of the day
NFL Biosciences S.A. NFL Biosciences S.A.

NFL Biosciences S.A.

ALNFL
Rangering i aksjer #31528
Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL... Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.
Aksjekurs
$1.02
Markedsverdi
$12.96M
Endring (1 dag)
-0.92%
Endring (1 år)
-43.11%
Land
FR
Handel NFL Biosciences S.A. (ALNFL)

Kategori

P/S-forhold for NFL Biosciences S.A. (ALNFL)
P/S-forhold per 2026 TTM: 0
Ifølge NFL Biosciences S.A. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for NFL Biosciences S.A. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
10.17 -
US
10.13 -
NL
2.95 -
AU
- -
CH
- -
KR